Pending Bills
Current psychedelic, cannabis, kratom and 7-OH proposals, newest action first, each linked to its legislature.
Bills still moving only. Enacted, failed, superseded, stalled and unconfirmed bills are left out; see the full Bill Tracker for those.
96 pending bills
- New Jersey · KratomS2271Pending
CJ’s Law (2026–2027)
· Transferred to Senate Law and Public Safety.
Official bill page (opens in a new tab) - Michigan · KratomSB1181Pending
Kratom Consumer Protection Act (2025–2026)
· Referred to Senate Regulatory Affairs.
Official bill page (opens in a new tab) - New Jersey · 7-OHA5359Pending
7-hydroxymitragynine scheduling (2026–2027)
· Referred to Assembly Judiciary.
Official bill page (opens in a new tab) - United States · KratomH.R. 10272Pending
End Gas Station Heroin Act (119th Congress (2025–2026))
· Referred to House Energy and Commerce and Judiciary.
Official bill page (opens in a new tab) - California · PsychedelicsSB1224Pending
The California Emerging Therapies Research Partnership Act. (2026 Session)
· August 13 hearing: Held in committee and under submission.
Official bill page (opens in a new tab) - United States · KratomS. 5383Pending
End Gas Station Heroin Act (119th Congress (2025–2026))
· Read twice; referred to Senate Judiciary.
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH4200Pending
An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities (194th General Court (2025–2026))
· Referred
Official bill page (opens in a new tab) - United States · KratomH.R. 9913Pending
Safe Sips Act of 2026 (119th Congress (2025–2026))
· Referred to House Energy and Commerce and Ways and Means.
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH2203Pending
Establishing a pilot program for access to regulated psilocybin (2026 Session)
· Referred
Official bill page (opens in a new tab) - United States · PsychedelicsHB9559Pending
IBOGAINE Act (119th Congress)
· Referred
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH4986Pending
Relative to therapeutic psilocybin treatment centers (2026 Session)
· Reporting date extended to Thursday, December 31, 2026
Official bill page (opens in a new tab) - Arizona · PsychedelicsSB1752Pending
Mescaline; possession; sale; commercial use (2026 Session)
· Assigned to House RULES Committee
Official bill page (opens in a new tab) - Michigan · KratomHB4969Pending
Kratom product regulation (2025–2026)
· Re-referred to House Regulatory Reform.
Official bill page (opens in a new tab) - Michigan · PsychedelicsHB6020Pending
Health: research; participation in ibogaine clinical trials; provide for (2025–2026 Regular Session)
· Committee Report
Official bill page (opens in a new tab) - New York · 7-OHS8925Pending
7-OH product restrictions (2025–2026)
· Passed Assembly and returned to Senate.
Official bill page (opens in a new tab) - Illinois · PsychedelicsSB2772Pending
Psilocybin Advisory Board (104th General Assembly (2025–2026))
· Referred
Official bill page (opens in a new tab) - California · PsychedelicsAB2489Pending
Controlled substances: research. (2026 Session)
· In committee: Held under submission.
Official bill page (opens in a new tab) - New York · PsychedelicsA02142Pending
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)
· print number 2142a
Official bill page (opens in a new tab) - New York · PsychedelicsS05303Pending
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)
· PRINT NUMBER 5303A
Official bill page (opens in a new tab) - Missouri · PsychedelicsHB2817Pending
Creates provisions relating to ibogaine treatment (2026 Session)
· Placed Back on Formal Perfection Calendar (H)
Official bill page (opens in a new tab) - Missouri · PsychedelicsHB1717Pending
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
· Committee Report
Official bill page (opens in a new tab) - New Hampshire · PsychedelicsHB1809Pending
Authorizing the medical use of psilocybin through a program established in the department of health and human services. (2026 Session)
· Inexpedient to Legislate, Motion Adopted, Voice Vote === BILL KILLED ===; 05/07/2026; Senate Journal 11
Official bill page (opens in a new tab) - North Carolina · PsychedelicsS1018Pending
The HEAL Act. (2025-2026 Session)
· Referred
Official bill page (opens in a new tab) - Iowa · PsychedelicsHF978Pending
A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.) (2026 Session)
· Amendment S-5248 filed. S.J. 960.
Official bill page (opens in a new tab) - Hawaii · PsychedelicsSB3199Pending
Relating To Mental Health. (2026 Session)
· Conference committee meeting to reconvene on 05-01-26 3:15PM; Conference Room 329.
Official bill page (opens in a new tab) - Minnesota · PsychedelicsSF3971Pending
Psilocybin therapeutic use program establishment (2026 Session)
· Author added Seeberger
Official bill page (opens in a new tab) - Minnesota · PsychedelicsHF4577Pending
Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated. (2026 Session)
· Motion to recall and re-refer, motion prevailed Veterans and Military Affairs Division
Official bill page (opens in a new tab) - Rhode Island · PsychedelicsH7756Pending
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. (2026 Session)
· Withdrawn at sponsor's request
Official bill page (opens in a new tab) - Hawaii · PsychedelicsSB1042Pending
Relating To Mental Health. (2026 Session)
· Received notice of the discharge of all House Conferees (Hse. Com. No. 457).
Official bill page (opens in a new tab) - Illinois · PsychedelicsSB2184Pending
USE AND RESEARCH-ENTHEOGENS (2026 Session)
· Referred
Official bill page (opens in a new tab) - Illinois · PsychedelicsHB2992Pending
HOPE PILOT PROGRAM (2026 Session)
· Referred
Official bill page (opens in a new tab) - Illinois · PsychedelicsHB1143Pending
Illinois CURE Act (an act concerning health) (104th General Assembly (2025–2026))
· Referred
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH1726Pending
Relative to criminal disposition of limited psilocybin possession offenses (2026 Session)
· Accompanied a study order, see H5281 (under House Rule 27)
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH1624Pending
Establishing a task force to study equitable access to psilocybin and other entheogenic plants (2026 Session)
· Accompanied a study order, see H5281 (under House Rule 27)
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH1858Pending
Relative to removing criminal penalties for limited psilocybin possession (2026 Session)
· Accompanied a study order, see H5281 (under House Rule 27)
Official bill page (opens in a new tab) - Pennsylvania · KratomSB 899Pending
Kratom product regulation (2025–2026)
· Laid on table under Senate Rule 9.
Official bill page (opens in a new tab) - Hawaii · PsychedelicsSCR171Pending
Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)
· Referred
Official bill page (opens in a new tab) - Hawaii · PsychedelicsSR162Pending
Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)
· Referred
Official bill page (opens in a new tab) - United States · 7-OHH.R. 8000Pending
END 7-OH Act (119th Congress (2025–2026))
· Referred to House Energy and Commerce and Judiciary.
Official bill page (opens in a new tab) - Minnesota · PsychedelicsSF4485Pending
Psilocybin therapeutic use program establishment (2026 Session)
· Introduced
Official bill page (opens in a new tab) - Idaho · PsychedelicsH0899Pending
Adds to existing law to establish the Medical Advanced Healing Act. (2026 Session)
· Introduced
Official bill page (opens in a new tab) - New Jersey · 7-OHS301Pending
7-hydroxymitragynine scheduling (2026–2027)
· Reported favorably; referred to Senate Budget and Appropriations.
Official bill page (opens in a new tab) - Florida · PsychedelicsH0309Pending
Controlled Substances (2026 Session)
· Laid on Table, refer to CS/SB 432
Official bill page (opens in a new tab) - Minnesota · PsychedelicsSF4204Pending
Psilocybin regulation provisions (2026 Session)
· Introduced
Official bill page (opens in a new tab) - United States · PsychedelicsSB4031Pending
Innovative Therapies Centers of Excellence Act (119th Congress)
· Introduced
Official bill page (opens in a new tab) - Georgia · PsychedelicsHB1296Pending
Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide (2026 Session)
· Referred
Official bill page (opens in a new tab) - Rhode Island · PsychedelicsH7925Pending
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations. (2026 Session)
· Introduced
Official bill page (opens in a new tab) - Michigan · PsychedelicsSB0802Pending
Controlled substances: conduct associated with qualified psychoactive substances exempt from criminal penalties in certain circumstances (2025–2026 Regular Session)
· Introduced
Official bill page (opens in a new tab) - Missouri · PsychedelicsHB2961Pending
Creates provisions relating to ibogaine treatment (2026 Session)
· Committee Report
Official bill page (opens in a new tab) - Missouri · PsychedelicsHB1643Pending
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
· Committee Report
Official bill page (opens in a new tab) - Kansas · PsychedelicsHB2218Pending
Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. (2026 Session)
· House Stricken from Calendar by Rule 1507
Official bill page (opens in a new tab) - New Jersey · KratomA4222Pending
Kratom consumer protection (2026–2027)
· Referred to Assembly Consumer Affairs.
Official bill page (opens in a new tab) - Arizona · PsychedelicsSB1542Pending
Controlled substances; approval; use; research (2026 Session)
· Committee Report
Official bill page (opens in a new tab) - Maryland · PsychedelicsHB1477Pending
Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)
· Introduced
Official bill page (opens in a new tab) - Oklahoma · PsychedelicsHB4293Pending
Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date. (2026 Session)
· Referred
Official bill page (opens in a new tab) - Maryland · PsychedelicsSB527Pending
Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)
· Hearing 2/24 at 1:00 p.m.
Official bill page (opens in a new tab) - Iowa · PsychedelicsSF2151Pending
A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2026 Session)
· Subcommittee: Sweeney, Donahue, and Webster. S.J. 214.
Official bill page (opens in a new tab) - Washington · PsychedelicsSB5921Pending
Concerning psilocybin. (2026 Session)
· Referred
Official bill page (opens in a new tab) - Vermont · PsychedelicsH0859Pending
An act relating to psychedelic therapy and clinical drug development trials (2026 Session)
· Introduced
Official bill page (opens in a new tab) - United States · PsychedelicsHB7091Pending
Expanding Veterans’ Access to Emerging Treatments Act (2026 Session)
· Referred
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsS1113Pending
Relative to removing criminal penalties for limited psilocybin possession (2026 Session)
· Accompanied a study order, see S2930
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH2506Pending
Decriminalizing psilocybin as a treatment for PTSD and certain other conditions (2026 Session)
· Accompanied a new draft, see H4986
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsH2532Pending
Relative to therapeutic psilocybin treatment centers (2026 Session)
· Accompanied a new draft, see H4986
Official bill page (opens in a new tab) - Iowa · PsychedelicsHF2085Pending
A bill for an act relating to the production and administration of psilocybin and providing penalties. (2026 Session)
· Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).
Official bill page (opens in a new tab) - Pennsylvania · PsychedelicsSB1149Pending
Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)
· Introduced
Official bill page (opens in a new tab) - New York · PsychedelicsA09583Pending
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program. (2026 Session)
· Introduced
Official bill page (opens in a new tab) - New Jersey · KratomS1384Pending
Kratom Consumer Protection Act (2026–2027)
· Referred to Senate Commerce.
Official bill page (opens in a new tab) - New Jersey · KratomA1203Pending
CJ’s Law (2026–2027)
· Referred to Assembly Judiciary.
Official bill page (opens in a new tab) - New Jersey · KratomA1617Pending
CJ’s Law — kratom restrictions (2026–2027)
· Referred to Assembly Consumer Affairs.
Official bill page (opens in a new tab) - Washington · PsychedelicsHB1433Pending
Concerning access to psychedelic substances. (2026 Session)
· By resolution, reintroduced and retained in present status.
Official bill page (opens in a new tab) - Washington · PsychedelicsSB5201Pending
Concerning access to psychedelic substances. (2026 Session)
· By resolution, reintroduced and retained in present status.
Official bill page (opens in a new tab) - Washington · PsychedelicsSB5204Pending
Concerning ibogaine-assisted therapy. (2026 Session)
· By resolution, reintroduced and retained in present status.
Official bill page (opens in a new tab) - New York · PsychedelicsS01801Pending
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)
· PRINT NUMBER 1801A
Official bill page (opens in a new tab) - New York · PsychedelicsA03845Pending
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)
· print number 3845a
Official bill page (opens in a new tab) - New York · PsychedelicsA03775Pending
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)
· Referred
Official bill page (opens in a new tab) - New York · PsychedelicsS00495Pending
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)
· Referred
Official bill page (opens in a new tab) - New York · PsychedelicsS04664Pending
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. (2026 Session)
· Referred
Official bill page (opens in a new tab) - New York · PsychedelicsA01522Pending
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2026 Session)
· Referred
Official bill page (opens in a new tab) - New York · PsychedelicsA00628Pending
Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions. (2026 Session)
· Referred
Official bill page (opens in a new tab) - Pennsylvania · KratomHB 2058Pending
Kratom product regulation (2025–2026)
· Referred to House Health.
Official bill page (opens in a new tab) - Massachusetts · PsychedelicsS1400Pending
Authorizing a pilot for the use of psychedelics in licensed treatment facilities (2025 Session)
· Referred
Official bill page (opens in a new tab) - Michigan · PsychedelicsHB4686Pending
Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. (2025 Session)
· Introduced
Official bill page (opens in a new tab) - Pennsylvania · PsychedelicsHB1439Pending
Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)
· Introduced
Official bill page (opens in a new tab) - United States · PsychedelicsHB2623Pending
Innovative Therapies Centers of Excellence Act of 2025 (2025 Session)
· Referred
Official bill page (opens in a new tab) - Illinois · KratomHB3215Pending
Illinois Kratom Consumer Protection Act (2025–2026)
· Rule 19(a): re-referred to Rules Committee.
Official bill page (opens in a new tab) - Pennsylvania · KratomSB 233Pending
Kratom Consumer Protection Act (2025–2026)
· Referred to Health and Human Services.
Official bill page (opens in a new tab) - United States · PsychedelicsHB4242Pending
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. (2023 Session)
· Referred
Official bill page (opens in a new tab) - United States · PsychedelicsHB3684Pending
Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023 (2023 Session)
· Introduced
Official bill page (opens in a new tab) - Hawaii · PsychedelicsSR88Pending
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older. (2022 Session)
· Certified copies of resolutions sent, 06/06/22.
Official bill page (opens in a new tab) - Brazil · PsychedelicsPL 579/2024Pending
Bill to treat personal possession as drug trafficking
No dated action recorded
Official bill page (opens in a new tab) - Ecuador · CannabisPopular citizens' initiative (2025)Pending
Organic Law for the Comprehensive Regulation of the Responsible Use of Cannabis in Ecuador
No dated action recorded
Official bill page (opens in a new tab) - Netherlands · PsychedelicsKamerstuk 24 077, nr. 567Pending
Motion on a pilot of MDMA-assisted therapy for people with severe PTSD [Motie van de leden Mutluer en Sneller over een pilot met MDMA-ondersteunde therapie voor mensen met ernstige PTSS] (2025-2026)
No dated action recorded
Official bill page (opens in a new tab) - New York · KratomS8136Pending
Enacts the New York State Kratom Consumer Protection Act (2025)
No dated action recorded
Official bill page (opens in a new tab) - Paraguay · CannabisExpediente D-2476902Pending
Bill regulating the cultivation, production, sale and medicinal and recreational use of cannabis and its derivatives (2024)
No dated action recorded
Official bill page (opens in a new tab) - Suriname · CannabisPending
Industrial Hemp Cultivation Act (Wet Industriële Hennepteelt)
No dated action recorded
Official bill page (opens in a new tab) - Venezuela · PsychedelicsPending
Partial Reform of the Organic Law on Drugs
No dated action recorded
Official bill page (opens in a new tab)